Sign Up to like & get recommendations! 0
Published in 2021 at "ESC heart failure"
DOI: 10.1002/ehf2.13713
Abstract: AIMS Chronic heart failure with reduced ejection fraction remains a major health issue. To date, no reliable biomarker is available to predict reduced left ventricular ejection fraction (LV-EF). We aimed to identify novel circulating biomarkers… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14055
Abstract: To describe clinical characteristics and outcomes for those with STEMI and reduced left ventricular ejection fraction (LVEF) in low‐income and middle‐income countries (LMICs). read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Life Sciences"
DOI: 10.1016/j.lfs.2017.05.025
Abstract: Aims: Atrial fibrillation (AF) is associated with fibrosis that slows electrical conduction and causes perpetuation of the arrhythmia. The molecular characterization of AF pathophysiology may provide novel therapeutic options. This study was designed to elucidate… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Interactive Cardiovascular and Thoracic Surgery"
DOI: 10.1093/icvts/ivac095
Abstract: Abstract OBJECTIVES Surgical revascularization is an established indication for patients with advanced coronary artery disease and reduced left ventricular ejection fraction (LVEF). Long-term outcomes for these patients are not well-defined. We studied the long-term outcomes… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Laboratory medicine"
DOI: 10.1093/labmed/lmac162
Abstract: OBJECTIVE Reduced left ventricular ejection fraction (LVEF) is common in hemodialysis (HD) patients. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is considered an important determinant of cardiovascular events. The aim of the study was to evaluate the relationship… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Echocardiography"
DOI: 10.1111/echo.15892
Abstract: The extraaortic‐valvular cardiac damage (EVCD) Stage has shown potential for risk stratification for patients with aortic stenosis (AS). This study aimed to examine the usefulness of the EVCD Stage in risk stratification of patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Cardiac Surgery"
DOI: 10.1111/jocs.16927
Abstract: Atrial fibrillation (AF) is common in patients with reduced left ventricle ejection fraction (RLVEF). The impact of concomitant surgical atrial fibrillation ablation (SAFA) in patients with RLVEF is uncertain. The purpose of this study was… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Stroke"
DOI: 10.1161/strokeaha.123.045623
Abstract: Reduced left ventricular ejection fraction ≤40%, a known risk factor for adverse cardiac outcomes and recurrent acute ischemic stroke, may be detected during an acute ischemic stroke hospitalization. A multidisciplinary care paradigm informed by neurology… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "BMC Cardiovascular Disorders"
DOI: 10.1186/s12872-024-03867-2
Abstract: To examine the prognostic value of superoxide dismutase (SOD) activity for monitoring reduced left ventricular ejection fraction(LVEF)in the patients with type 2 diabetes and acute coronary syndrome (ACS). The population of this cross-sectional study included… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2024.1368139
Abstract: Background Pulmonary hypertension (PH) is a common prognostic factor for acute myocardial infarction (AMI) and its impact may increase when combined with reduced left ventricular function. Methods This retrospective cohort study enrolled AMI patients with… read more here.